SCHEMBL347425

SCHEMBL347425

CC1Sc2ccccc2N1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.45
▸ GPR3 P46089 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ PTPN2 P17706 1/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ KDM1A O60341 3/20 0.35
▸ NOX1 Q9Y5S8 2/20 0.34
▸ ADRA2A P08913 2/20 0.34
▸ ADRA2B P18089 2/20 0.34
▸ ADRA2C P18825 2/20 0.34
▸ CHRM3 P20309 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29814962 1.00 MAOA (0.45) MAOAGPR3ALDH1A1SMN1; SMN2KDM4E
SCHEMBL16728889 1.00 MAOA (0.45) MAOAGPR3ALDH1A1SMN1; SMN2KDM4E
Iodide SCHEMBL17092835 0.98 MAOA (0.43) MAOAGPR3ALDH1A1SMN1; SMN2KDM4E
Iodide SCHEMBL28378810 0.96 MAOA (0.42) MAOAGPR3ALDH1A1SMN1; SMN2KDM4E
Sulfuric Acid SCHEMBL28551070 0.89 BCHE (0.39) MAOAALDH1A1SMN1; SMN2GSK3BMEN1
SCHEMBL11684678 0.89 MAPT (0.41) MAOAGPR3ALDH1A1SMN1; SMN2HPGD
SCHEMBL12264201 0.80 MAOA (0.46) MAOAGPR3ALDH1A1SMN1; SMN2GSK3B
SCHEMBL16709179 0.79 MAOA (0.42) MAOAALDH1A1SMN1; SMN2KDM4EGSK3B
SCHEMBL19362157 0.77 MAOA (0.39) MAOAALDH1A1SMN1; SMN2GSK3BPTPN2
SCHEMBL1156077 0.77 MAOA (0.43) MAOAGPR3ALDH1A1SMN1; SMN2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114874638-B Meso-position substituted pentamethine cyanine dye, preparation method and application thereof, and fluorescent probe 西安建筑科技大学 2024-01-19 — — CN claimed
CN-116103711-A Forward and reverse pulse electrolytic nickel-phosphorus alloy solution, preparation method, electroplating method and nickel-phosphorus alloy coating 安徽智备工业科技有限公司 2023-05-12 — — CN claimed
US-10683273-B2 Compounds as DNA probes, methods and applications thereof JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2020-06-16 — — US claimed
US-20190135769-A1 COMPOUNDS AS DNA PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2019-05-09 — — US claimed
US-20180251478-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2018-09-06 — — US claimed
EP-3341365-A1 COMPOUNDS AS DNA PROBES, METHODS AND APPLICATIONS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2018-07-04 — — EP claimed
EP-3341384-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF Jawaharlal Nehru Centre For Advanced Scientific Research (IN) 2018-07-04 — — EP claimed
WO-2017033163-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2017-03-02 — — WO claimed
WO-2017033162-A1 COMPOUNDS AS DNA PROBES, METHODS AND APPLICATIONS THEREOF JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) 2017-03-02 — — WO claimed
EP-1778176-B1 COMPOSITION FOR COLOURING KERATIN-CONTAINING FIBRES HENKEL AG & CO KGAA (DE) 2012-07-25 — — EP claimed
EP-1500387-A1 Use of ninhydrin derivatives for dyeing L'OREAL (FR) 2005-01-26 — — EP claimed
EP-1037586-B1 UTILIZATION OF ONIUM ALDEHYDES AND ONIUM KETONES FOR DYING FIBERS CONTAINING KERATIN HENKEL KGAA (DE) 2004-12-22 — — EP claimed
US-6790239-B1 COMBINATION OF AROMATIC ALDEHYDES OR KETONES AND CH-ACTIVE COMPOUNDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-09-14 — — US claimed
US-6770102-B1 AROMATIC ALDEHYDES OR KETONES AND CH-ACTIVE COMPOUNDS; DOES NOT REQUIRE OXIDIZING AGENT; BRILLIANCE; COLOR DEPTH; WIDE VARIETY OF SHADES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-08-03 — — US claimed
EP-1139990-B1 AGENT FOR DYING KERATIN FIBERS HENKEL KGAA (DE) 2004-05-06 — — EP claimed
EP-1303311-A2 AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF Neurochem, Inc. (CA) 2003-04-23 — — EP claimed
EP-1139988-B1 AGENT FOR DYING KERATIN FIBERS HENKEL KGAA (DE) 2002-09-25 — — EP claimed
US-20020115717-A1 Amyloid targeting imaging agents and uses thereof NEUROCHEM (INTERNATIONAL) LIMITED (GI) 2002-08-22 — — US claimed
WO-2002007781-A2 AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF NEUROCHEM INC. (CA) 2002-01-31 — — WO claimed
EP-0053851-B1 NOVEL ANTIFOGGING COMPOUNDS AND THEIR USE IN SILVER HALIDE PHOTOGRAPHY AGFA-GEVAERT N.V. (BE) 1985-05-29 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115717-A1 Amyloid targeting imaging agents and uses thereof APP, APBA1, BACE1 MAOA 886/4885GPR3 1769/4885ALDH1A1 3305/4885
US-10683273-B2 Compounds as DNA probes, methods and applications thereof TOP2B, TOP1, TOP2A MAOA 1439/4885GPR3 2500/4885ALDH1A1 286/4885
US-20190135769-A1 COMPOUNDS AS DNA PROBES, METHODS AND APPLICATIONS THEREOF TOP2B, TOP1, TOP2A MAOA 1439/4885GPR3 2500/4885ALDH1A1 286/4885
US-20180251478-A1 COMPOUNDS AS STIMULI-RESPONSIVE PROBES, METHODS AND APPLICATIONS THEREOF ROS1, SQOR, NOX4 MAOA 527/4885GPR3 1074/4885ALDH1A1 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback